Entity

Time filter

Source Type


Kato F.,Tokyo Kamata Medical Center | Watanabe T.,Tokyo Kamata Medical Center | Murakoshi Y.,Tokyo Kamata Medical Center | Tsurui S.,Tokyo Kamata Medical Center | And 7 more authors.
Japanese Journal of Cancer and Chemotherapy | Year: 2014

Only hepatic metastasectomy has been shown to have a therapeutic effect for hepatic metastases of colorectal cancer if the primary tumor can be removed radically according to the 2014 guidelines of the Japanese Society for Cancer of the Colon and Rectum. However, only a few patients with hepatic metastases are candidates for metastasectomy due to tumor factors other than the hepatic metastases. Furthermore, hepatic metastasectomy is frequently judged to be impossible in older patients due to underlying diseases and surgical tolerability. In such cases, therefore, treatment is often difficult. Herein, we report 2 patients with hepatic metastases of colorectal cancer treated with radiofrequency ablation, raising the possibility of local control in the liver. Source


Kawaguchi M.,Tokyo Kamata Medical Center | Uchimura N.,Tokyo Kamata Medical Center | Okuda Y.,Tokyo Kamata Medical Center | Konuma S.,Tokyo Kamata Medical Center | Nehashi Y.,Tokyo Kamata Medical Center
[Rinshō ketsueki] The Japanese journal of clinical hematology | Year: 2015

Two multiple myeloma (MM) patients developed venous thromboembolism (VTE) while being treated with lenalidomide and low-dose dexamethasone. Aspirin is recommended for VTE prophylaxis when using lenalidomide/dexamethasone for MM patients with a standard risk of VTE. Despite aspirin administration, however, these two patients experienced VTE. Following VTE development, warfarin and then a Factor Xa inhibitor, edoxaban, were administered. The edoxaban treatment, especially, resulted in favorable and effective control of VTE. Considering these observations, Factor Xa inhibitors may in future become a preferred option for prevention and treatment of VTE when managing MM patients. Source


Kato F.,Tokyo Kamata Medical Center | Watanabe T.,Tokyo Kamata Medical Center | Murakoshi Y.,Tokyo Kamata Medical Center | Tsurui S.,Tokyo Kamata Medical Center | And 7 more authors.
Gan to kagaku ryoho. Cancer & chemotherapy | Year: 2014

Only hepatic metastasectomy has been shown to have a therapeutic effect for hepatic metastases of colorectal cancer if the primary tumor can be removed radically according to the 2014 guidelines of the Japanese Society for Cancer of the Colon and Rectum. However, only a few patients with hepatic metastases are candidates for metastasectomy due to tumor factors other than the hepatic metastases. Furthermore, hepatic metastasectomy is frequently judged to be impossible in older patients due to underlying diseases and surgical tolerability. In such cases, therefore, treatment is often difficult. Herein, we report 2 patients with hepatic metastases of colorectal cancer treated with radiofrequency ablation, raising the possibility of local control in the liver. Source

Discover hidden collaborations